NCT01913730View on ClinicalTrials.gov

Maintenance Therapy With Subcutaneous Bortezomib

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

April 30, 2021

Study Completion Date

September 7, 2023

Conditions
Multiple Myeloma
Interventions
DRUG

Bortezomib

DRUG

Dexamethasone

Trial Locations (1)

Unknown

Irccs Crob, Rionero in Vulture

All Listed Sponsors
collaborator

Fondazione EMN Italy Onlus

OTHER

lead

European Myeloma Network B.V.

NETWORK

NCT01913730 - Maintenance Therapy With Subcutaneous Bortezomib | Biotech Hunter | Biotech Hunter